• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONVATEC LTD DUODERM PASTE AND GELS; DRESSING, WOUND, HYDROGEL WITHOUT DRUG AND/OR BIOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONVATEC LTD DUODERM PASTE AND GELS; DRESSING, WOUND, HYDROGEL WITHOUT DRUG AND/OR BIOLOGIC Back to Search Results
Model Number 187987
Medical Device Problem Codes Delivered as Unsterile Product (1421); Device Damaged Prior to Use (2284); Tear, Rip or Hole in Device Packaging (2385); Contamination /Decontamination Problem (2895)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/25/2024
Type of Reportable Event Malfunction
Event or Problem Description
To date no additional patient or event details have been received.
 
Additional Manufacturer Narrative
Additional information - this emdr is being submitted to include the below: h6 - investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions.A batch record review was completed and no discrepancies were found.Duoderm h/active gel (3tbex30g) ster us was manufactured under system application product (sap) code 1002859 and manufacturing lot number 3h00021 on 31 august 2023.Lot # 3h00021 was sterilised under andersen caledonia batch ssp170823-1 and released on review of results of sterilisation provided by sterilisation company andersen caledonia.All of the results were within specification and products were released.No nonconformity was identified during the manufacturing process of lot 3h00021.This is the first complaint out of 2 for the affected lot registered within database.This complaint is for a hole and leakage in the tube, and the other complaint is for dented tube.Both complaints are related and identify two malfunctions for the same primary tube.1 photograph was received for this issue and has been evaluated in accordance with work instructions (wi).The photograph confirms the product and the complaint issue where the back of the tube exhibits damage at the base of the tube.There is evidence of dried gel on the tube crimp and above where a dark perforation is seen in the tube.A nonconformance was not opened for this complaint issue.As per work instructions (wi), acceptable quality level (aql) is identified as 4.0 for primary pack appearance or 0.65 for contamination.As the batch size is over (b)(4) primary units, a single primary pack affected by the contamination would be acceptable in a sample of (b)(4) units.No further complaints have been received against this batch.The aluminium tubes used in this batch would have been provided by supplier (b)(4).As it is unlikely that the tube could have been in this condition before filling, contacting the supplier would not be necessary.The supplier has since ceased trading, so would not be possible anyway.It is likely this imperfection would have been observable at the point of packing, so is unlikely to have been pack.It is possible to have been caused at the point of packing.As the secondary packaging is not damaged it is unlikely for the damage to have been sustained during transit.The complaint was escalated to the distribution quality team, and it was identified the secondary packs are relabelled for local malaysia market.This includes opening the secondary pack to insert an instructions for use (ifu).As no nonconformance was identified during the relabelling process, it is most likely that the damage has been sustained during the relabelling process at the distribution centre.This issue will be monitored through the post market product monitoring review process.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092.Manufacturing site: 1000317571.
 
Additional Manufacturer Narrative
E1: complainant street address, complainant city, complainant state, complainant postal code, complainant phone, complainant country.Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 1000317571.
 
Event or Problem Description
It was reported by the distributor that there was a hole/leakage on one unit of company's sterile gel tube and the packaging was intact.The product was not used on patient.A photograph depicting the issue was received from complainant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUODERM PASTE AND GELS
Common Device Name
DRESSING, WOUND, HYDROGEL WITHOUT DRUG AND/OR BIOLOGIC
Manufacturer (Section D)
CONVATEC LTD
first avenue
deeside industrial park
deeside, flintshire CH5 2 NU
UK  CH5 2NU
Manufacturer (Section G)
CONVATEC LTD
first avenue
deeside industrial park
deeside, flintshire CH5 2 NU
UK   CH5 2NU
Manufacturer Contact
pamela meadows
7815 national service road
suite 600
greensboro, NC 27409
3365424679
MDR Report Key19141140
Report Number1000317571-2024-00025
Device Sequence Number18003024
Product Code NAE
UDI-Device Identifier00768455172979
UDI-Public00768455172979
Combination Product (Y/N)N
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Distributor
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 03/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date08/01/2026
Device Model Number187987
Device Lot Number3H00021
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer04/19/2024
Initial Report FDA Received Date04/19/2024
Supplement Report FDA Received Date05/09/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/31/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
-
-